Description

Zonik (pregabalin) hard capsules 150 mg. №28

Ingredients

Active ingredient: Pregabalin 150 mg.
Other ingredients: Lactose monohydrate, maize starch, talc, gelatin, titanium dioxide (E171), and coloring agents.

Dosage

Recommended dosage: The usual dose is 150 mg daily, divided into two or three doses. Dosage may vary based on individual response and medical condition.

Indications

Zonik (pregabalin) 150 mg capsules are indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, and as adjunctive therapy for adults with partial-onset seizures.

Contraindications

Do not use Zonik (pregabalin) capsules if:

• You are allergic to pregabalin or any other ingredients in the product.
• You have heart problems or a history of drug or alcohol abuse.
• You are pregnant or breastfeeding.

Directions

How to take Zonik (pregabalin) capsules: Swallow the capsules whole with water. It can be taken with or without food. Follow your healthcare provider’s instructions for the best results.

Scientific Evidence

Pregabalin has been extensively studied for its efficacy in treating neuropathic pain and seizures. Clinical trials have shown that pregabalin significantly reduces pain intensity and improves quality of life in patients with neuropathic pain conditions. Studies have also demonstrated its effectiveness in reducing the frequency of seizures when used as an adjunctive therapy.

Additional Information

Precautions: Inform your doctor about all medications you are taking before starting pregabalin. Avoid alcohol while taking this medication as it may increase the risk of side effects. Regular monitoring may be required for certain conditions like renal impairment.

In conclusion, Zonik (pregabalin) 150 mg capsules offer a well-established treatment option for neuropathic pain and seizures. Its mechanism of action involves binding to calcium channels in the central nervous system, modulating neurotransmitter release and reducing neuronal excitability.

Compared to other antiepileptic drugs, pregabalin has shown similar efficacy with a more favorable side effect profile in some studies. It is considered a first-line treatment for neuropathic pain and is recommended by guidelines such as those from the American Academy of Neurology.